Identification of novel proteins associated with movement-related adverse antipsychotic effects by integrating GWAS

Jiqing Li1, Jicheng Pang2, Shucheng Si1

  • 1Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 Culture West Road, Jinan, Shandong 250012, China; Healthcare Big Data Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China.

Psychiatry Research
|August 28, 2022
PubMed

Insights

This study identifies 56 candidate proteins linked to movement-related adverse antipsychotic effects (MAAE) using probabilistic Mendelian randomization. These findings offer new biological insights and potential therapeutic targets for MAAE.

Area of Science:

  • Neuroscience
  • Pharmacogenomics
  • Genetics

Background:

  • Genome-wide association studies (GWAS) have identified genetic variants associated with movement-related adverse antipsychotic effects (MAAE).
  • The biological mechanisms by which these variants confer MAAE remain largely unknown.
  • Understanding these mechanisms is crucial for developing safer antipsychotic treatments.

Purpose of the Study:

  • To identify candidate proteins and biological pathways involved in MAAE using a genetic approach.
  • To explore the overlap between MAAE candidate proteins and Parkinson's disease (PD) motor symptoms.
  • To provide novel targets for mechanistic and therapeutic research into MAAE.

Main Methods:

  • Probabilistic Mendelian randomization (PMR) was employed to integrate MAAE GWAS data with protein quantitative trait loci (pQTL) data.
  • Confirmatory PMR was performed using independent pQTL and brain-derived eQTL data.
  • Associations between identified candidate proteins and Parkinson's disease motor symptoms were investigated. Enrichment analysis was conducted for Gene Ontology (GO) terms and pathways.

Main Results:

  • A total of 56 candidate proteins for MAAE were identified after FDR correction, including GRIN2B, ADRA1A, and PED4B.
  • Replication in confirmatory analyses yielded 12 genes, with 18 showing consistent transcript-level evidence.
  • Significant associations were found between candidate proteins and PD (24 proteins), PD motor subtypes (38 proteins), and PD motor progression (10 proteins).
  • Enrichment analysis highlighted 34 GO terms and 17 pathways, such as glutamatergic synapse and GABAergic synapse, potentially involved in MAAE.

Conclusions:

  • This study successfully identified multiple candidate genes and pathways implicated in MAAE.
  • The findings provide valuable insights into the biological underpinnings of MAAE.
  • The identified targets warrant further investigation for potential therapeutic interventions for MAAE.